Trial record 1 of 1 for:
NCT04432649
Targeting CD276 (B7-H3) Positive Solid Tumors by 4SCAR-276
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04432649 |
|
Recruitment Status :
Recruiting
First Posted : June 16, 2020
Last Update Posted : June 16, 2020
|
Sponsor:
Shenzhen Geno-Immune Medical Institute
Collaborators:
Sun Yat-sen University
Shenzhen Children's Hospital
Information provided by (Responsible Party):
Lung-Ji Chang, Shenzhen Geno-Immune Medical Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 31, 2023 |
| Estimated Study Completion Date : | May 31, 2024 |